Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial (Q46433026)

From Wikidata
Jump to navigation Jump to search
scientific article published in April 2005
edit
Language Label Description Also known as
English
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial
scientific article published in April 2005

    Statements

    Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial (English)
    Visudyne in Minimally Classic Choroidal Neovascularization Study Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit